>
Has A Global Catastrophe Been Averted, Or Is This Just A Very Temporary Reprieve?
Blocking The Internet Archive Won't Stop AI, But It Will Erase The Web's Historical Record
Here is why Nasdaq and owner of NYSE are putting the $126 trillion equity market on blockchain
JFK: The Memo That Might Have Stopped Israel's War on Iran
We Build and Test Microwave Blocking Panels - Invisible to Radar
Man Successfully Designs mRNA Vaccine To Treat His Dog's Cancer
Watch: Humanoid robot gets surprisingly good at tennis
Low-cost hypersonic rocket engine takes flight for US Air Force
Your WiFi Can See You. Here's How.
Decentralizing Defense: A $96 Guided Rocket Just Put Precision Warfare into the Hands of the People
Israel's Iron Beam and the laser future of missile defense
Scientists at the Harbin University of Science and Technology have pioneered a sophisticated...
Researchers have developed a breakthrough "molecular jackhammer" technique...
Human trials are underway for a drug that regrows human teeth in just 4 days.

Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research. Coordinated Global Alliance for Vaccines and Immunisation's Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA) and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates. Highlighting the principle of using a prophylactic vaccine in the midst of a pandemic. Likely to create more more viral variants in the process.